Pressemitteilungen
Letzte Veröffentlichungen:
Double the number of patients at half the cost: digital innovation in Mohs surgery
The worldwide increase in cancer, predicted by the International Agency for Research on Cancer (IARC), requires the urgent optimisation and digitalisation of current treatment processes. A pioneering study led by Prof. Dr Jan Gutermuth at the University Hospital of Brussels presents a revolutionary approach: the integration of Ex Vivo Confocal Microscopy (EVCM) during Mohs Micrographic Surgery (MMS) for Basal Cell Carcinoma (BCC) using the VivaScope 2500, which has been proven to enable a more precise and faster assessment of tumour extension and resection margins, leading to a significant increase in efficiency. Prof Dr Jan Gutermuth and his team have proven that the waiting time for patients has been reduced, costs have been more than halved and the quality of patient care has been improved. The results have far-reaching implications for the healthcare system by enabling more effective and cost-efficient treatment of skin cancer.
Milestone at Vienna General Hospital: VivaScope revolutionises cancer diagnosis and treatment in Austria
In Austria, around 42,000 people are diagnosed with cancer every year. Although this is a matter of health and therefore the greatest human good, the analogue frozen section – a technique first used in 1895 – is still considered the gold standard for intraoperative pathological assessment when removing tumour tissue. With its „Ex Vivo“ technology, the company VivaScope is bringing about a fundamental medical revolution. Thanks to digital optical sections, tumour tissue can be removed more efficiently than ever before and assessed within five minutes using telemedicine. The VivaScope 2500 is now being used for the first time in the field of dermatology at Vienna General Hospital.
New hope for people suffering from pancreatic cancer
Revolutionary study results thanks to the VivaScope 2500 laser scanning microscope.
Economic value of the VivaScope 1500 In Vivo microscope
Extensive large-scale clinical trial demonstrated the therapeutic & economic value of the VivaScope 1500 In Vivo microscope in early diagnosis of Melanoma lesions.
Priv.-Doz. Dr. Daniela Hartmann wins the „German Medical Award“
Great success also for VivaScope, the specialist for confocal laser scanning microscopy, because the VivaScope 2500 was part of it.
Aktuelle Publikationen in Verbindung mit unserer Technologie:
Economic value of the VivaScope 1500 In Vivo microscope
Extensive large-scale clinical trial demonstrated the therapeutic & economic value of the VivaScope 1500 In Vivo microscope in early diagnosis of Melanoma lesions.
Milestone at Vienna General Hospital: VivaScope revolutionises cancer diagnosis and treatment in Austria
In Austria, around 42,000 people are diagnosed with cancer every year. Although this is a matter of health and therefore the greatest human good, the analogue frozen section – a technique first used in 1895 – is still considered the gold standard for intraoperative pathological assessment when removing tumour tissue. With its „Ex Vivo“ technology, the company VivaScope is bringing about a fundamental medical revolution. Thanks to digital optical sections, tumour tissue can be removed more efficiently than ever before and assessed within five minutes using telemedicine. The VivaScope 2500 is now being used for the first time in the field of dermatology at Vienna General Hospital.